- Report
- April 2025
- 50 Pages
Global
From €2476EUR$2,650USD£2,094GBP
- Report
- February 2025
- 77 Pages
Global
From €3500EUR$4,013USD£3,065GBP
Zinc Bacitracin is an antibiotic used to treat a variety of infectious diseases. It is a polypeptide antibiotic derived from the bacterium Bacillus subtilis, and is used to treat skin and soft tissue infections, as well as respiratory and urinary tract infections. It is also used to prevent infections in burn patients and to treat infections caused by Gram-positive bacteria. Zinc Bacitracin is available in both oral and topical forms, and is often used in combination with other antibiotics.
Zinc Bacitracin is a widely used antibiotic in the treatment of infectious diseases, and is often used in combination with other antibiotics to treat more serious infections. It is generally well tolerated, with few side effects. It is also relatively inexpensive, making it an attractive option for many patients.
Some companies in the Zinc Bacitracin market include Pfizer, Merck, GlaxoSmithKline, Sanofi, and Novartis. Show Less Read more